Comparison of Eylea® with Lucentis® as first-line therapy in patients with treatment-naïve neovascular age-related macular degeneration in real-life clinical practice: retrospective case-series…

Overview of attention for article published in BMC Ophthalmology, August 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (73rd percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 7,786 followers.

[VEGF] Comparison of Eylea® with Lucentis® as first-line therapy in patients with treatment-naïve neovascul... https://t.co/v9PlLEmoyi PM

Comparison of Eylea® with Lucentis® as first-line therapy in patients with treatment-naïve neovascular age-related… https://t.co/kqZk0GlHaK

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.